Cell therapies: Realizing the potential of this new dimension to medical therapeutics

Journal of Tissue Engineering and Regenerative Medicine

Volumn 2, Issue 6, 2008, Pages 307-319

  Singh, Pawanbir ^a   Williams, David J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

Author keywords

Cell therapies; Clinical trials; Medical therapeutics; Regenerative medicine; Stem cells; Translational research requirements

Indexed keywords

CLINICAL RESEARCH; CYTOLOGY; REGENERATIVE MEDICINE;

CELL THERAPY; CLINICAL TRIAL; CONDITION; EMBRYONIC TISSUE; MEDICAL THERAPEUTIC; NEW DIMENSIONS; REGENERATIVE MEDICINE; STEM-CELL; TRANSLATIONAL RESEARCH; TRANSLATIONAL RESEARCH REQUIREMENT;

STEM CELLS;

ACUTE HEART INFARCTION; ADIPOSE STEM CELL; ALZHEIMER DISEASE; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS; EMBRYONIC STEM CELL; ENDOTHELIAL STEM CELL; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLAST; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL TRANSPLANTATION; ANIMAL; CYTOLOGY; GENERAL ASPECTS OF DISEASE; METHODOLOGY; REGENERATIVE MEDICINE; STEM CELL;

ANIMALS; DISEASE; HUMANS; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 60749105605     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.108     Document Type: Review

References (175)

1. American Diabetes Association. 2004; Diagnosis and classification of diabetes mellitus. Diabetes Care 27(suppl 1): S5-10. American Heart Association. 2007; Heart Disease and Stroke Statistics - 2007 Update. American Heart Association: Dallas, TX; 1-43.
2. Alison MR, Poulsom R, Forbes S, et al. 2002; An introduction to stem cells. J Pathol 197(4): 419-423.
3. Alvarez-Dolado M. 2007; Cell fusion: biological perspectives and potential for regenerative medicine. Front Biosci 12: 1-12.
4. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. 2003; Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425(6961): 968-973.
5. Amado LC, Saliaris AP, Schuleri KH, et al. 2005; Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102(32): 11474-11479.
6. Anderson WS, Lenz FA. 2006; Surgery insight: deep brain stimulation for movement disorders. Nat Clin Pract Neurol 2(6): 310-320.
7. Archer R, Williams DJ. 2005; Why tissue engineering needs process engineering. Nat Biotechnol 23(11): 1353-1355.
8. Archundia A, Aceves JL, Lopez-Hernandez M, et al. 2005; Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction. Life Sci 78(3): 279-283.
9. Askari A, Unzek S, Goldman CK, et al. 2004; Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischaemic cardiomyopathy. J Am Coll Cardiol 43(10): 1908-1914.
10. Assmus B, Honold J, Schachinger V, et al. 2006; Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355(12): 1222-1232.
11. Assmus B, Walter DH, Lehmann R, et al. 2006; Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction. Eur Heart J 27(24): 2989-2995.
12. Auld DS, Kornecook TJ, Bastianetto S, et al. 2002; Alzheimer's disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68(3): 209-245.
13. Aurich I, Mueller LP, Aurich H, et al. 2007; Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 56(3): 405-415.
14. Barbash IM, Chouraqui P, Baron J, et al. 2003; Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7): 863-868.
15. Bates CM, Lin F. 2005; Future strategies in the treatment of acute renal failure: growth factors, stem cells, and other novel therapies. Curr Opin Pediatr 17(2): 215-220.
16. Becker D, Sadowsky CL, McDonald JW. 2003; Restoring function after spinal cord injury. Neurologist 9(1): 1-15.
17. Beeres SL, Bengel FM, Bartunek J, et al. 2007; Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol 49(11): 1137-1148.
18. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. 2002; Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99(4): 2344-2349.
19. Blyszczuk P, Czyz J, Kania G, et al. 2003; Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 100(3): 998-1003.
20. Blyszczuk P, Wobus AM. 2006; In vitro differentiation of embryonic stem cells into the pancreatic lineage. Methods Mol Biol 330: 373-385.
21. Borgens RB. 2003; Restoring function to the injured human spinal cord. Adv Anat Embryol Cell Biol 171: III-IV, 1-155.
22. Bottino R, Lemarchand P, Trucco M, et al. 2003; Gene- and cellbased therapeutics for type I diabetes mellitus. Gene Ther 10(10): 875-889.
23. Brolen GK, Heins N, Edsbagge J, et al. 2005; Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing β-cell-like cells. Diabetes 54(10): 2867-2874.
24. Burns CJ, Minger SL, Hall S, et al. 2005; The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem Biophys Res Commun 326(3): 570-577.
25. Cao LZ, Tang DQ, Horb ME, et al. 2004; High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes 53(12): 3168-3178.
26. Chang CM, Kao CL, Chang YL, et al. 2007; Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem Biophys Res Commun 357(2): 414-420.
27. Chen S, Liu Z, Tian N, et al. 2006; Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischaemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 18(11): 552-556.
28. Chen SL, Fang WW, Ye F, et al. 2004; Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94(1): 92-95.
29. Cho HJ, Lee J,Wecker A, et al. 2006; Bone marrow-derived stem cell therapy in ischaemic heart disease. Regen Med 1(3): 337-345.
30. Choi KS, Shin JS, Lee JJ, et al. 2005; In vitro trans-differentiation of ratmesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun 330(4): 1299-1305.
31. Colucci-D'Amato L, Bonavita V, di Porzio U. 2006; The end of the central dogma of neurobiology: stem cells and neurogenesis in adult CNS. Neurol Sci 27(4): 266-270.
32. Davies KE, Grounds MD. 2006; Treating muscular dystrophy with stem cells? Cell 127(7): 1304-1306.
33. DeFronzo RA, Ferrannini E, Keen H, et al. 2004; International Textbook of Diabetes Mellitus, 3rd edn. Wiley: Chichester, UK.
34. Ding Q, Dimayuga E, Keller JN. 2007; Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res 4(1): 73-79.
35. EberhardtM, Salmon P, von MachMA, et al. 2006; Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun 345(3): 1167-1176.
36. Eftekharpour E, Karimi-Abdolrezaee S, Wang J, et al. 2007; Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci 27(13): 3416-3428.
37. El-Badri NS, Hakki A, Saporta S, et al. 2006; Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells Dev 15(4): 497-506.
38. Ende N, Chen R, Reddi AS. 2004; Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 321(1): 168-171.
39. Fernandez-Aviles F, San Roman JA, Garcia-Frade J, et al. 2004; Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95(7): 742-748.
40. Frangioni JV, Hajjar RJ. 2004; In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110(21): 3378-3383.
41. Freed CR, Breeze RE, Rosenberg NL, et al. 1992; Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327(22): 1549-1555.
42. Freed CR, Greene PE, Breeze RE, et al. 2001; Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344(10): 710-719.
43. Fujita Y, Cheung AT, Kieffer TJ. 2004; Harnessing the gut to treat diabetes. Pediatr Diabetes 5(suppl 2): 57-69.
44. Gepts W, Lecompte PM. 1981; The pancreatic islets in diabetes. Am J Med 70(1): 105-115.
45. Gillogly SD, Myers TH, Reinold MM. 2006; Treatment of fullthickness chondral defects in the knee with autologous chondrocyte implantation. J Orthop Sports Phys Ther 36(10): 751-764.
46. Gooding CR, Bartlett W, Bentley G, et al. 2006; A prospective, randomised study comparing two techniques of autologous chondrocyte implantation for osteochondral defects in the knee: periosteum covered versus type I/III collagen covered. Knee 13(3): 203-210.
47. Graham JJ, Lederman RJ, Dick AJ. 2006; Magnetic resonance imaging and its role in myocardial regenerative therapy. Regen Med 1(3): 347-355.
48. Hagell P, Piccini P, Bjorklund A, et al. 2002; Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 5(7): 627-628.
49. Haller MJ, Viener HL,Wasserfall C, et al. 2008; Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol (in press).
50. Hansson M, Tonning A, Frandsen U, et al. 2004; Artifactual insulin release from differentiated embryonic stem cells. Diabetes 53(10): 2603-2609.
51. Harding SE, Ali NN, Brito-Martins M, et al. 2007; The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacol Ther 113(2): 341-353.
52. Hess D, Li L, Martin M, et al. 2003; Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21(7): 763-770.
53. Hishikawa K, Fujita T. 2006; Stem cells and kidney disease. Hypertens Res 29(10): 745-749.
54. Ho HY, Li M. 2006; Potential application of embryonic stem cells in Parkinson's disease: drug screening and cell therapy. Regen Med 1(2): 175-182.
55. Hogan P, Dall T, Nikolov P. 2003; Economic costs of diabetes in the US in 2002. Diabetes Care 26(3): 917-932.
56. Hori Y, Gu X, Xie X, et al. 2005; Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med 2(4): e103.
57. Hou M, Yang KM, Zhang H, et al. 2007; Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 115(2): 220-228.
58. Ince H, Petzsch M, Rehders TC, et al. 2004; Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 11(6): 695-704.
59. Isacson O. 2002; Models of repair mechanisms for future treatment modalities of Parkinson's disease. Brain Res Bull 57(6): 839-846.
60. Iso Y, Spees JL, Serrano C, et al. 2007; Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 354(3): 700-706.
61. Ito T, Shimada K, Gang M, et al. 2007; Pancreas transplantation using type I and type II spontaneously diabetic rats - our experimental experience. Microsurgery 27(4): 305-311.
62. Jackson KA, Majka SM, Wang H, et al. 2001; Regeneration of ischaemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107(11): 1395-1402.
63. Jackson L, JonesDR, Scotting P, et al. 2007; Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53(2): 121-127.
64. Jenner P, Olanow CW. 1998; Understanding cell death in Parkinson's disease. Ann Neurol 44(3): suppl 1): S72-84.
65. Jiang W, Shi Y, Zhao D, et al. 2007; In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res 17(4): 333-344.
66. Johansson BB. 2007; Regeneration and plasticity in the brain and spinal cord. J Cereb Blood Flow Metab 27(8): 1417-1430.
67. Kang HJ, Kim HS, Koo BK, et al. 2007; Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with GCSF and Intra-Coronary Stem Cell Infusion MAGIC Cell 1 trial. Am Heart J 153(2): 237, e231-238.
68. Kawamoto A, Asahara T. 2007; Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv 70(4): 477-484.
69. Keirstead HS, Nistor G, Bernal G, et al. 2005; Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25(19): 4694-4705.
70. Kemp P. 2006; History of regenerative medicine: looking backwards to move forwards. Regen Med 1(5): 653-669.
71. Klein C, Schlossmacher MG. 2006; The genetics of Parkinson disease: implications for neurological care. Nat Clin Pract Neurol 2(3): 136-146.
72. + stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10(1): E66-69.
73. Kocher AA, Schuster MD, Szabolcs MJ, et al. 2001; Neovascularization of ischaemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7(4): 430-436.
74. Kodama S, Davis M, Faustman DL. 2005; Diabetes and stem cell researchers turn to the lowly spleen. Sci Aging Knowledge Environ 2005(3): pe2.
75. Krause U, Harter C, Seckinger A, et al. 2007; Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev 16(1): 31-37.
76. Kuethe F, Richartz BM, Sayer HG, et al. 2004; Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 97(1): 123-127.
77. Lang AE, Lozano AM. 1998a; Parkinson's disease [first of two parts]. N Engl J Med 339(15): 1044-1053.
78. Lang AE, Lozano AM. 1998b; Parkinson's disease [second of two parts]. N Engl JMed 339(16): 1130-1143.
79. Lee DY, Lee JH, Yang JM, et al. 2006; A new dermal equivalent: the use of dermal fibroblast culture alone without exogenous materials. J Dermatol Sci 43(2): 95-104.
80. Lee H, Al Shamy G, Elkabetz Y, et al. 2007; Directed differentiation and transplantation of human embryonic stem cell derived motoneurons. Stem Cells 25: 1931-1939.
81. Lee N, Thorne T, Losordo DW, Yoon YS. 2005; Repair of ischaemic heart disease with novel bone marrow-derived multipotent stem cells. Cell Cycle 4(7): 861-864.
82. Lee RH, Seo MJ, Reger RL, et al. 2006; Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103(46): 17438-17443.
83. + cells enhance function and repair of the infarcted myocardium. Stem Cells 24(3): 772-780.
84. Leshnower BG, Gleason TG, O'Hara ML, et al. 2006; Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann Thorac Surg 81(4): 1365-1370; discussion, 1370-1361.
85. Lindvall O, Sawle G, Widner H, et al. 1994; Evidence for longterm survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 35(2): 172-180.
86. + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115(25): 3165-3172.
87. Lu L, Zhao C, Liu Y, et al. 2005; Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Brain Res Protoc 15(1): 46-51.
88. Lumelsky N, Blondel O, Laeng P, et al. 2001; Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292(5520): 1389-1394.
89. Lunde K, Solheim S, Aakhus S, et al. 2007; Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 154(4): 710, e711-718.
90. Lyngbaek S, Schneider M, Hansen JL, et al. 2007; Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Res Cardiol 102(2): 101-114.
91. Lysaght MJ, Hazlehurst AL. 2003; Private sector development of stem cell technology and therapeutic cloning. Tissue Eng 9(3): 555-561.
92. Lysaght MJ, Reyes J. 2001; The growth of tissue engineering. Tissue Eng 7(5): 485-493.
93. Mangi AA, Noiseux N, Kong DH, et al. 2003; Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9(9): 1195-1201.
94. Marin DB, Sewell MC. Schlechter A. 2002; Alzheimer's disease. Accurate and early diagnosis in the primary care setting. Geriatrics 57(2): 36-40; quiz, 43.
95. Martin JB. 1999; Molecular basis of the neurodegenerative disorders. N Engl J Med 340(25): 1970-1980.
96. Massa M, Rosti V, Ferrario M, et al. 2005; Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105(1): 199-206.
97. Mazhari R, Hare JM. 2007; Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4(suppl 1): S21-26.
98. McKenzie IA, Biernaskie J, Toma JG, et al. 2006; Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system. J Neurosci 26(24): 6651-6660.
99. Min JY, Huang X, Xiang M, et al. 2006; Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac Cardiovasc Surg 131(4): 889-897.
100. Minger SL, Ekonomou A, Carta EM, et al. 2007; Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2(1): 69-74.
101. Miyazaki S, Yamato E, Miyazaki J. 2004; Regulated expression of pdx-1 promotes in vitro differentiation of insulin-producing cells from embryonic stem cells. Diabetes 53(4): 1030-1037.
102. Mooney DJ, Mikos AG. 1999; Growing new organs. Sci Am 280(4): 60-65.
103. Nelson TJ, Ge ZD, Van Orman J, et al. 2006; Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat Rec A DiscovMol Cell Evol Biol 288(11): 1216-1224.
104. Nygren JM, Jovinge S, Breitbach M, et al. 2004; Bone marrowderived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10(5): 494-501.
105. Ogawa Y, Sawamoto K, Miyata T, et al. 2002; Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res 69(6): 925-933.
106. Oh SH, Muzzonigro TM, Bae SH, et al. 2004; Adult bone marrowderived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest 84(5): 607-617.
107. OhSH, WitekRP, BaeSH, et al. 2007; Bone marrowderived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 132(3): 1077-1087.
108. Olanow CW, Freeman T, Kordower J. 2001; Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 345(2): 146; author reply, 147.
109. Olanow CW, Goetz CG, Kordower JH, et al. 2003; A doubleblind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54(3): 403-414.
110. OrlicD, Kajstura J, ChimentiS, et al. 2001; Bone marrow cells regenerate infarcted myocardium. Nature 410(6829): 701-705.
111. Oyama T, Nagai T, Wada H, et al. 2007; Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176(3): 329-341.
112. Ozbaran M, Omay SB, Nalbantgil S, et al. 2004; Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischaemic heart disease. Eur J Cardiothorac Surg 25(3): 342-350; discussion, 350-341.
113. Park SJ, TectorA, PiccioniW, et al. 2005; Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129(1): 9-17.
114. Perin EC, Lopez J. 2006; Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med 3(suppl 1): S110-113.
115. Pessina A, Eletti B, Croera C, et al. 2004; Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun 323(1): 315-322.
116. Piasecki SD, Jefferson JW. 2004; Psychiatric complications of deep brain stimulation for Parkinson's disease. J Clin Psychiat 65(6): 845-849.
117. Piccini P, Brooks DJ, Bjorklund A, et al. 1999; Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 2(12): 1137-1140.
118. Piccini P, Pavese N, Hagell P, et al. 2005; Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 128(12): 2977-2986.
119. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147.
120. Prunier F, PfisterO, Hadri L, et al. 2007; Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells. Am J Physiol Heart Circ Physiol 292(1): H522-529.
121. Puceat M. 2006; Stem cell therapy in heart failure: where do we stand and where are we heading? Heart Fail Monit 5(2): 44-49.
122. Qian H, Yang Y, Huang J, et al. 2007; Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy- glucose: tissue distribution and impact on postinfarct swine hearts. J Cell Biochem 102(1): 64-74.
123. Rajagopal J, Anderson WJ, Kume S, et al. 2003; Insulin staining of ES cell progeny from insulin uptake. Science 299(5605): 363.
124. Redmond DE Jr, Sladek JR, Spencer DD. 2001; Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 345(2): 146-147.
125. Reppel M, Igelmund P, Egert U, et al. 2007; Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 19(5-6): 213-224.
126. Retuerto MA, Beckmann JT, Carbray J, et al. 2007; Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts. J Thorac Cardiovasc Surg 133(2): 478-484, e472.
127. Rietze RL, Reynolds BA. 2006; Neural stem cell isolation and characterization. Methods Enzymol 419: 3-23.
128. Ripa RS, Haack-Sorensen M, Wang Y, et al. 2007; Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction STEMMI trial. Circulation 116(11): suppl): I24-30.
129. Ryan EA, Lakey JR, Rajotte RV, et al. 2001; Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50(4): 710-719.
130. Samson SL, Chan L. 2006; Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 17(3): 92-100.
131. San Roman JA, Fernandez-Aviles F. 2006; The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction. Nat Clin Pract Cardiovasc Med 3(suppl 1): S38-41.
132. Sanberg PR. 2007; Neural stem cells for Parkinson's disease: to protect and repair. Proc Natl Acad Sci USA 104(29): 11869-11870.
133. Sanberg PR, Willing AE, Garbuzova-Davis S, et al. 2005; Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci 1049: 67-83.
134. Sanchez Alvarado A, Tsonis PA. 2006; Bridging the regeneration gap: genetic insights from diverse animal models. Nat Rev Genet 7(11): 873-884.
135. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. 2005; Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111(22): 2981-2987.
136. Scolding N, Franklin R, Stevens S, et al. 1998; Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121(12): 2221-2228.
137. Segev H, Fishman B, Ziskind A, et al. 2004; Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells 22(3): 265-274.
138. Sgubin D, Aztiria E, Perin A, et al. 2007; Activation of endogenous neural stem cells in the adult human brain following subarachnoid hemorrhage. J Neurosci Res 85(8): 1647-1655.
139. Shalitin S, Phillip M. 2006; Closing the loop: combining insulin pumps and glucose sensors in children with type 1 diabetes mellitus. Pediatr Diabetes 7(suppl 4): 45-49.
140. Shapiro AM, Lakey JR, Ryan EA, et al. 2000; Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoidfree immunosuppressive regimen. N Engl JMed 343(4): 230-238.
141. Shastri VP. 2006; Future of regenerative medicine: challenges and hurdles. Artif Organs 30(10): 828-834.
142. Sicat BL, Morgan LA. 2007; New therapeutic options for the management of diabetes. Consult Pharm 22(1): 45-56.
143. Sipione S, Eshpeter A, Lyon JG, et al. 2004; Insulin expressing cells from differentiated embryonic stem cells are not β cells. Diabetologia 47(3): 499-508.
144. Soria B, Roche E, Berna G, et al. 2000; Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocininduced diabetic mice. Diabetes 49(2): 157-162.
145. Soria B, Skoudy A, Martin F. 2001; From stem cells to β cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44(4): 407-415.
146. Stamm C, Kleine HD, Choi YH, et al. 2007; Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischaemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133(3): 717-725.
147. Steindler DA. 2007; Stem cells, regenerative medicine, and animal models of disease. Ilar J 48(4): 323-338.
148. Steiner B, Wolf S, Kempermann G. 2006; Adult neurogenesis and neurodegenerative disease. Regen Med 1(1): 15-28.
149. Stock UA, Vacanti JP. 2001; Tissue engineering: current state and prospects. Annu Rev Med 52: 443-451.
150. Sugaya K. 2005; Possible use of autologous stem cell therapies for Alzheimer's disease. Curr Alzheimer Res 2(3): 367-376.
151. Sugaya K, Alvarez A, Marutle A, et al. 2006; Stem cell strategies for Alzheimer's disease therapy. Panminerva Med 48(2): 87-96.
152. TangDQ, Cao LZ, BurkhardtBR, et al. 2004; In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53(7): 1721-1732.
153. Tarasenko YI,Gao J,Nie L, et al. 2007; Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res 85(1): 47-57.
154. Thomas B, Flet JG, Shyam R, et al. 2007; Chronic respiratory complications in pediatric heart transplant recipients. J Heart Lung Transpl 26(3): 236-240.
155. Thomas RJ, Chandra A, Liu Y, et al. 2007; Manufacture of a human mesenchymal stem cell population using an automated cell culture platform. Cytotechnology 55(1): 31-39.
156. Thompson CA, Nasseri BA, Makower J, et al. 2003; Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 41(11): 1964-1971.
157. Timper K, Seboek D, Eberhardt M, et al. 2006; Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 341(4): 1135-1140.
158. Tse HF, Kwong YL, Chan JK, et al. 2003; Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361(9351): 47-49.
159. Tse HF, Siu CW, Zhu SG, et al. 2007; Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 9(8): 747-753.
160. Tuszynski MH, Thal L, Pay M, et al. 2005; A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11(5): 551-555.
161. Vanhorebeek I, Langouche L, Van den Berghe G. 2007; Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 132(1): 268-278.
162. Vilela Filho O, Silva DJ, Souza HA, et al. 2001; Stereotactic subthalamic nucleus lesioning for the treatment of Parkinson's disease. Stereotact Funct Neurosurg 77(1-4): 79-86.
163. Wang Q, Matsumoto Y, Shindo T, et al. 2006; Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J Med Invest 53(1-2): 61-69.
164. Werner L, Deutsch V, Barshack I, et al. 2005; Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. J Mol Cell Cardiol 39(4): 691-697.
165. Wild S, Roglic G, Green A, et al. 2004; Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5): 1047-1053.
166. Williams DJ, Ratchev S, Chandra A, et al. 2006; The application of assembly and automation technologies to healthcare products. CIRP Ann Manufact Technol 55(2): 617-642.
167. Wollert KC, Meyer GP, Lotz J, et al. 2004; Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364(9429): 141-148.
168. Wu KH, Zhou B, Yu CT, et al. 2007; Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg 83(4): 1491-1498.
169. Yamaoka T. 2003; Regeneration therapy for diabetes mellitus. Exp Opin Biol Ther 3(3): 425-433.
170. Yang LJ. 2006; Liver stem cell-derived β-cell surrogates for treatment of type 1 diabetes. Autoimmun Rev 5(6): 409-413.
171. +-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108(17): 2070-2073.
172. Yu M, Zhang C, Zhang Y, et al. 2007; BM stem cell transplantation rescues pathophysiologic features of aged dystrophic mdxmuscle. Cytotherapy 9(1): 44-52.
173. Zhang D, Zhang F, Zhang Y, et al. 2007; Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair. Transpl Int 20(2): 174-183.
174. Zhang DZ, Gai LY, Liu HW, et al. 2007; Transplantation of autologous adipose-derived stem cells ameliorates cardiac function in rabbits with myocardial infarction. Chin Med J Engl 120(4): 300-307.
175. Zhang S, Ge J, Sun A, et al. 2006; Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99(4): 1132-1147.